, DrugsControl Media Services
, DrugsControl Media Services DrugsControl Media Services DrugsControl.org News Detail » » » » » » » »…
Public hospitals record 26 serious medication errors in first quarter
Hong Kong’s public hospitals recorded 26 serious untoward events involving medication errors in the first quarter of the…
TGA approves new severe asthma treatment Exdensur for Australians
A newly registered asthma treatment has been given the green light by the Therapeutic Goods of Australia (TGA),…
GLP-1s Had a Surprising Effect on the Liver in a New Study
Type 2 diabetic patients were among the very first groups to experience the positive effects of semaglutides and…
Hairdressers selling ‘Ozempic’: SA’s wild weight loss market
A recent high-profile court judgment halting a Pretoria pharmacy from selling GLP-1 drugs at scale has seemingly done…
Doctors And GLP-1 Users Respond To Trump’s ‘Fat Drugs’ Comments
The use of GLP-1s is skyrocketing throughout the world; 11% of American adults report taking the medications, up…
UAE becomes second country to approve Lipfendra, new once-daily pill for high LDL cholesterol
The Emirates Drug Establishment urged the public, particularly people with high cholesterol, to maintain a healthy lifestyle that…
Weight loss injections: Breaking down the essentials, from costs to alternatives
This article was reviewed by Craig Primack, MD, FACP, FAAP, FOMA. Weight loss can be a challenge, even…
UAE becomes second country to approve new oral pill for high cholesterol
The UAE has approved a once-daily oral medicine for adults with high levels of bad cholesterol, becoming the…
Older adults taking 5 or more prescription drugs face higher risk of death, study finds
article Ranbaxy Laboratories Ltd.’s Atorvastatin Calcium Tablets IP Storvas 10 tablets are arranged for a photograph in Mumbai,…
Us Fda: US FDA nod for 1st pill to replace jabs to fight high cholesterol | India News
NEW DELHI: Patients with difficult-to-control high cholesterol could soon have an oral alternative to cholesterol-lowering injections after US…
Compounded GLP-1 Receptor Agonists Remain Widely Available
HealthDay News — Despite the end of nationwide shortages of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), the market…